Insider Transactions in Q2 2023 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Habib J Dable |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+28.57%
|
-
|
|
Jun 21
2023
|
John Tsai |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+28.57%
|
-
|
|
Jun 21
2023
|
Lynn Seely |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+19.1%
|
-
|
|
Jun 21
2023
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+13.97%
|
-
|
|
Jun 21
2023
|
Jeffrey W. Albers |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+1.46%
|
-
|
|
Jun 21
2023
|
Daniella Beckman |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+23.21%
|
-
|
|
Jun 21
2023
|
Nicholas Lydon |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+4.45%
|
-
|
|
Jun 21
2023
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+3.49%
|
-
|
|
Jun 21
2023
|
Lonnel Coats |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+19.1%
|
-
|
|
Jun 05
2023
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,307
-5.71%
|
$119,964
$52.06 P/Share
|
|
Jun 05
2023
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,404
-3.67%
|
$73,008
$52.05 P/Share
|